Higher Rates Of Amputation And Ketoacidosis With Sglt2 Inhibitors: European Registry Data | Latest News RSS feed

Higher Rates Of Amputation And Ketoacidosis With Sglt2 Inhibitors: European Registry Data - Latest News

Zackary Berger’s weekly research reviews—19 November

Perhaps because only chain pharmacies were contacted, or because telephone rather than in-person data were collected, the availability was higher ... SGLT2 inhibitors were lower limb amputations and d... read more

Bolstering your armamentarium with SGLT2 inhibitors

Abstract: Sodium-glucose cotransporter-2 inhibitors have a unique mechanism of action in the kidneys Journal Logo Secondary Logo Account Saved Searches Recent Searches Register Activate Subscription L... read more

Novo Nordisk A/S (NVO) Q1 2018 Results - Earnings Call Transcript

Where what happens is that as the SGLT-2 inhibitor takes down glucose levels ... labels and say there are elements of slight risk of diabetic ketoacidosis, some overrepresentation of amputations, some ... read more

Looking for another news?

Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes

In the post hoc analysis of 18-week data ... of SGLT2 inhibitors as early therapy in patients with type 2 diabetes. Results from large-scale cardiovascular safety studies of incretin-based therapies a... read more

Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research

Despite methodological challenges, high-quality observational studies have an important role in comparative effectiveness research because they can address issues that are otherwise difficult or impos... read more

Top Stocks Set to Disrupt the Diabetes Market

Market Data Latest News read more

Five New Studies at Major Medical Meeting Further Demonstrate Clinical Experience for JANUVIA

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--New data analyses presented at the 44 th Annual Meeting of the European Association ... events occurring at an incidence rate greater than or equal to three ... read more

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes Free

Author Contributions: Conception and design: J.J. Chamberlain, A.S. Rhinehart, C.F. Schaefer. Analysis and interpretation of the data: J.J. Chamberlain, A.S. Rhinehart. Drafting of the article: J.J. C... read more

Dr. Syed Yusuf

Dr. Syed Yusuf is an oncologist in Houston, Texas and is affiliated with University of Texas MD Anderson Cancer Center. He received his medical degree from Dow University of Health Sciences and has be... read more

Type 2 Diabetes

The SGLT-2 inhibitor group ... polled phase 2 & 3 data did not indicate any adverse signals related to amputation & fracture (6). So where do we stand as of now? Empagliflozin remains the gold standar... read more

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

In patients with type 2 diabetes, premixed insulin analogs may help achieve lower A1C levels than long-acting insulin analogs used alone, but rates of hypoglycemia are typically higher ... glucose tra... read more

Bolstering your armamentarium with SGLT2 inhibitors

7-9 Studies also show modest decreases in systolic BP (3 mm Hg to 5 mm Hg) and diastolic BP (approximately 2 mm Hg) without a compensatory increase in heart rate. 10 In addition, treatment with an SGL... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us